Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SHBG | P04278 | 4/20 | 0.64 |
| ▸ | G6PD | P11413 | 3/20 | 0.64 |
| ▸ | SERPINA6 | P08185 | 2/20 | 0.64 |
| ▸ | ESR1 | P03372 | 1/20 | 0.64 |
| ▸ | AR | P10275 | 1/20 | 0.64 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.64 |
| ▸ | LMNA | P02545 | 1/20 | 0.64 |
| ▸ | GUSB | P08236 | 1/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.64 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.64 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.64 |
| ▸ | TSHR | P16473 | 1/20 | 0.64 |
| ▸ | CYP17A1 | P05093 | 9/20 | 0.64 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.64 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18925198 | 1.00 | SHBG (0.64) | SHBGG6PDSERPINA6ESR1AR | |
| SCHEMBL9939193 | 1.00 | SHBG (0.64) | SHBGG6PDSERPINA6ESR1AR | |
| SCHEMBL14149814 | 1.00 | SHBG (0.64) | SHBGG6PDSERPINA6ESR1AR | |
| SCHEMBL3366382 | 1.00 | SHBG (0.64) | SHBGG6PDSERPINA6ESR1AR | |
| SCHEMBL12310691 | 1.00 | SHBG (0.64) | SHBGG6PDSERPINA6ESR1AR | |
| SCHEMBL23155091 | 1.00 | SHBG (0.64) | SHBGG6PDSERPINA6ESR1AR | |
| SCHEMBL13076860 | 1.00 | SHBG (0.64) | SHBGG6PDSERPINA6ESR1AR | |
| SCHEMBL13461623 | 1.00 | SHBG (0.64) | SHBGG6PDSERPINA6ESR1AR | |
| SCHEMBL11970666 | 1.00 | SHBG (0.64) | SHBGG6PDSERPINA6ESR1AR | |
| SCHEMBL336036 | 1.00 | SHBG (0.64) | SHBGG6PDSERPINA6ESR1AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119486721-A | Lipid nanoparticles comprising imidazolium-based cationic lipids | 宝利普拉斯生物转染公司 | 2025-02-18 | — | — | CN | claimed |
| CN-113473974-A | Pharmaceutical composition | 深圳市药欣生物科技有限公司 | 2021-10-01 | — | — | CN | claimed |
| US-20030113284-A1 | Use of DHEA derivatives on keratinous substances | L'OREAL (FR) | 2003-06-19 | — | — | US | claimed |
| EP-1306081-A1 | Cosmetic use of DHEA-derivatives | L'OREAL (FR) | 2003-05-02 | — | — | EP | claimed |
| US-6093389-A | CONTAINING A STEROID DERIVATIVE | AMERICAN CYANAMID COMPANY (US) | 2000-07-25 | — | — | US | claimed |
| EP-0749977-B1 | 17-hydroxyiminoalkyl and 17-hydroxyiminomethylalkenyl cyclopentaneperhydrophenanthrene derivatives active on the cardiovascular system, a process for their preparation and pharmaceutical compositions containing same | SIGMA TAU IND FARMACEUTI (IT) | 1999-08-18 | — | — | EP | claimed |
| US-5792759-A | STEROIDS, USEFUL FOR TREATEMENT OF HEART FAILURE AND HYPERTENSION | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 1998-08-11 | — | — | US | claimed |
| EP-0846417-A1 | Methods and compositions for attracting and controlling termites | American Cyanamid Company (US) | 1998-06-10 | — | — | EP | claimed |
| EP-0749977-A2 | Novel 17-hydroxyiminoalkyl and 17-hydroxyiminomethylalkenyl cyclopentaneperhydrophenanthrene derivatives active on the cardiovascular system, a process for their preparation and pharmaceutical compositions containing same | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) | 1996-12-27 | — | — | EP | claimed |
| EP-0087359-B1 | NITROMETHYLATING REAGENT, ITS UTILIZATION IN THE PREPARATION OF NITROMETHYLATED COMPOUNDS AND SOME OF THEIR DERIVATIVES AND THE COMPOUNDS OBTAINED | ROUSSEL-UCLAF (FR) | 1989-05-31 | — | — | EP | claimed |
| CN-119486721-A | Lipid nanoparticles comprising imidazolium-based cationic lipids | 宝利普拉斯生物转染公司 | 2025-02-18 | — | — | CN | disclosed |
| CN-119421871-A | Ionizable lipids | 伊泽阿恩埃免疫疗法股份有限公司 | 2025-02-11 | — | — | CN | disclosed |
| CN-119384272-A | Freeze-dried RNA composition | 伊泽阿恩埃免疫疗法股份有限公司 | 2025-01-28 | — | — | CN | disclosed |
| CN-119095588-A | Continuous rotary freeze drying of nucleic acid-containing compositions | 伊泽阿恩埃免疫疗法股份有限公司 | 2024-12-06 | — | — | CN | disclosed |
| CN-118647368-A | Method for mass production of large-size LNP | 伊泽阿恩埃免疫疗法股份有限公司 | 2024-09-13 | — | — | CN | disclosed |
| US-5604213-A | STEROID DEPENDENT CANCERS SUCH AS PROSTATE AND BREAST CANCER | BRITISH TECHNOLOGY GROUP LIMITED (GB) | 1997-02-18 | — | — | US | disclosed |
| EP-0749977-A2 | Novel 17-hydroxyiminoalkyl and 17-hydroxyiminomethylalkenyl cyclopentaneperhydrophenanthrene derivatives active on the cardiovascular system, a process for their preparation and pharmaceutical compositions containing same | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) | 1996-12-27 | — | — | EP | disclosed |
| EP-0633893-A1 | 17-SUBSTITUTED STEROIDS USEFUL IN CANCER TREATMENT | BRITISH TECHNOLOGY GROUP LTD (GB) | 1995-01-18 | — | — | EP | disclosed |
| WO-1993020097-A1 | 17-SUBSTITUTED STEROIDS USEFUL IN CANCER TREATMENT | BRITISH TECHNOLOGY GROUP LTD. (GB) | 1993-10-14 | — | — | WO | disclosed |
| EP-0135337-B1 | PREVENTIVE AND CURATIVE PREPARATION FOR THROMBOSIS | Bellex Corporation (JP) | 1989-07-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030113284-A1 | Use of DHEA derivatives on keratinous substances | SHBG, CYP21A2, NR5A1 | SHBG 1/4885G6PD 343/4885SERPINA6 44/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.